Progestogen-only injectable contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria

Akadri, Adebayo; Odelola, Oluseyi Isaiah

doi:10.4103/npmj.npmj_99_17

Cited by 10 publications

(11 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is comparable to 15.35% and 15.7% reported fromPort-Harcourt and Uyo [15,16] but higher than 12.6% and 14.2% reported in Ife and Jos [17,18]. However the study prevalence was lower than 26%, 45.17%, 23.3% and 21.55% reported from other parts of the country such as Isagamu, Port Harcourt, Calabar and Lagos [6,[19][20][21]. These variations noted in various regions of Nigeria could be as a result of sociocultural and religious beliefs as well as clients perception of the type of contraceptive [20].…”

Section: Discussionsupporting

confidence: 58%

Progesterone Only Injectable Contraceptives: A Five Year Review of Side Effects and Discontinuation Rate in a Teaching Hospital in Niger Delta, Nigeria

Ijeoma

Solomon

2020

AJMAH

View full text Add to dashboard Cite

Background: Progesterone only injectable contraceptives (POICs) are long acting reversible method of contraception used worldwide. Menstrual abnormalities are recognized side effects that can lead to discontinuation of these highly effective and safe contraceptives. Objectives: To determine the prevalence rate, side effects, discontinuation rate and indications for discontinuation of Norethisteroneenanthate (noristerat) and Depot Medroxyprogesterone acetate (depoprovera) at Rivers State University Teaching Hospital (RSUTH), Port Harcourt. Methods: A five year retrospective study of 874 clients attending family planning clinic at the RSUTH from 1st of January, 2015 – 31st of December, 2019. Their records were retrieved from the clinic and reviewed. Data was extracted, coded and analyzed using the statistical package for social sciences (SPSS) IBM version 25.0 (Armonk, NY). Chi square test was used as test of significance where applicable and a p-value <0.05 was considered statistically significant. Results: One hundred and thirty eight clients accepted and used POICs out of 874 acceptors of contraceptives within the study period giving a prevalence rate of 15.8%. Depot Medroxyprogesterone acetate was more preferred by the women. The modal age group was 25-34 years accounting for 86 (62.3%). Age range was 19-48 years and the modal parity was para 2. Majority of the clients had formal education, 137 (99.3%), married, 128 (92.8%) and multipara 85 (61.6%).The discontinuation rate was 31.9%and the commonest reason for discontinuation was irregular vaginal bleeding accounting for 25%. Conclusion: The prevalence rate of POICs was low and Depot Medroxyprogesterone acetate was more popular. Majority of the discontinuation was due to the side effects of the contraceptives.

show abstract

Section: Discussionsupporting

confidence: 58%

Progesterone Only Injectable Contraceptives: A Five Year Review of Side Effects and Discontinuation Rate in a Teaching Hospital in Niger Delta, Nigeria

Ijeoma

Solomon

2020

AJMAH

View full text Add to dashboard Cite

show abstract

“…2 Majority of the clients 173 (63.8%) were within the age of 30 to 39 years which is in keeping with the findings from other centres. 15,16 In this study, no adolescent used DMPA. This is similar to a study done in Uyo.…”

Section: Discussionmentioning

confidence: 93%

“…This is similar to findings in previous studies. 15,16,22 Only 1.9% of the clients heard about contraception from mass media indicating the poor role of media in disseminating information on contraception. Therefore there should be an increase in dissemination of information on the usefulness of contraception through the media in order to reduce maternal morbidity and mortality.…”

Section: Discussionmentioning

confidence: 99%

A ten year review of depot medroxyprogesterone acetate contraceptive use at Rivers State University Teaching Hospital, South Nigeria

Nonye-Enyidah¹,

Kasso

2020

Int J Adv Med

View full text Add to dashboard Cite

Background: Depo Medroxyprogesterone Acetate (DMPA) also known as Depo provera is a long acting progestogen-only contraceptive injection used by women worldwide. It is given deep intramuscularly at interval of 3 months. It is easy to use, effective, safe, convenient and reversible. Objective was to determine the prevalence of DMPA contraceptive method and profile of its acceptors at the RSUTH.Methods: This was a retrospective study of 271 clients attending family planning clinic at the RSUTH from 1st January, 2008 - 31st December, 2017. Their records were retrieved from the clinic and reviewed. Data was extracted, coded and analyzed using the statistical package for social sciences (SPSS) IBM version 25.0 (Armonk, NY).Results: The prevalence rate of DMPA contraceptive among contraceptive acceptors at the RSUTH within the study period was 14.3 %. The modal age group was 30-34 years accounting for 103 (38.0%). Age range was 20-51 years. Two hundred and sixty eight (98.9%) had formal education. Majority of the clients had secondary level of education 209 (77.1 %). Of the 271 acceptors of DMPA, 175 (64.6%) were multipara. Most of the clients were married 259 (95.6%) and of Christian religion 265 (97.8%). Clinical personnel were the commonest source of information, accounting for 228 (84.1%).Conclusions: The prevalence of DMPA use over the study period was low. There is need for more counseling and enlightenment campaign to encourage our women to use this effective and safe method of contraception.

show abstract

“…[7][8][9][10][11] However, this study prevalence was lower than 26%, 50% and 71.8% reported from Isagamu, Zaria and Abia in respectively in different geopolitical zones in Nigeria. [12][13][14] In general, there seems to be regional variation in the use progesterone only contraceptives which may be as a result of cultural and religious beliefs and individual client perception of the contraceptive method. 9 All the women in this study were married.…”

Section: Discussionmentioning

confidence: 99%

Weight gain and menstrual abnormalities between users of Depo-provera and Noristerat

Oshodi

Agbara

fashola

et al. 2019

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Progesterone only injectable contraceptive provides long acting contraception against unwanted pregnancy. Alterations in menstrual pattern are a well known side effect of this effective contraceptive method. Objective of this study was to compare the weight gain and pattern of menstrual abnormalities in users of Depot Medroxyprogesterone Acetate (DMPA) and Norethisterone Enanthate (Noristerat) in LASUTH.Methods: Retrospective comparative study conducted over a 3year period (January 2013 to December 2015) and involving 237 subjects who used injectable hormonal contraceptive (either DMPA or Noristerat). Case records of all the subjects were retrieved and information obtained on socio-demographic data, parity, previous contraceptive method and reason for discontinuation within one year of usage. Other information including subjects’ weight, menstrual cycle length and pattern, and side effects were collected at 3, 6 and 12 months for DMPA group and 2, 4 and 12 months interval for Noristerat group. Data obtained were analyzed using statistical packages for social sciences (version 19).Results: The combined mean age was 34.15±1.36 years. The mean weight at commencement was 68.16kg for DMPA and 66.61kg for Noristerat users while after a year, it significantly increased to 71.27kg for DMPA and 69.07kg for Noristerat users (P<0.05). No change in menstrual pattern was noted in 10% of DMPA and 7% of Noristerat users while 60% of DMPA and 57% of Noristerat had amenorrhoea by the end one year period. Five percent each of DMPA and Noristerat users perceived weight gain as problem significant enough to discontinue both methods respectively. Overall, 24% of DMPA and 19.1% of Noristerat users discontinued use after one year.Conclusions: There were significant weight gain between users of DMPA and Noristerat which was not considered a problem. Amenorrhoea was the commonest menstrual abnormality responsible for discontinuation of either method.

show abstract

Progestogen-only injectable contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria

Abstract: Acceptor prevalence and continuation rate of progestogen-only injectable contraceptive are low. There is need for more enlightenment campaigns to encourage women to use this effective method of contraception.

Cited by 10 publications

References 1 publication

Progesterone Only Injectable Contraceptives: A Five Year Review of Side Effects and Discontinuation Rate in a Teaching Hospital in Niger Delta, Nigeria

Progesterone Only Injectable Contraceptives: A Five Year Review of Side Effects and Discontinuation Rate in a Teaching Hospital in Niger Delta, Nigeria

A ten year review of depot medroxyprogesterone acetate contraceptive use at Rivers State University Teaching Hospital, South Nigeria

Weight gain and menstrual abnormalities between users of Depo-provera and Noristerat

Contact Info

Product

Resources

About